Anavex Life Sciences Corp (AVXL)

[ALP7]

A few months? 12-15 months is what you consider a few months?

Acadia's Phase 3 Lavender concluded October, 2021. Almost all patients entered the extended 9 month Lilac study. Acadia filed the NDA in July 2022 based on Lavender study results and the NDA was just approved.

This is Acadia's 2nd approved drug, and in 2022 they sold over $500M of Nuplazid. They have an established sales force. AVXL will be lucky if they are able to get 1000 Rett patients by end of 2025.